Diacetoxyscirpenol as a new anticancer agent to target hypoxia-inducible factor 1
Yong-Joon Choi(Seoul National University), Jong‐Wan Park(Seoul National University)
Cited by 18
Related Papers
Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1
|Blood|2008|158
Arrest Defective-1 Controls Tumor Cell Behavior by Acetylating Myosin Light Chain Kinase
|PLoS ONE|2009|72
Nuclear FGFR2 negatively regulates hypoxia-induced cell invasion in prostate cancer by interacting with HIF-1 and HIF-2
|Scientific Reports|2019|37
Reactive oxygen species‐mediated cyclin D1 degradation mediates tumor growth retardation in hypoxia, independently of p21<sup>cip1</sup> and hypoxia‐inducible factor
|Cancer Science|2008|15
PIN1 transcript variant 2 acts as a long non-coding RNA that controls the HIF-1-driven hypoxic response
|Scientific Reports|2019|12